Announcements Trials
Browse Landscape

Phase

Phase 2 49Phase 1 26Phase 3 13Phase 1/2 6Phase NA 5Phase 2/3 1

Status

Recruiting 2Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5Gastrointestinal 1

Conditions

Breast Neoplasms 3865Motor Activity 228Neoplasms 202Prostatic Neoplasms 167Colorectal Neoplasms 146Lung Neoplasms 139Lymphedema 125Fatigue 104Ovarian Neoplasms 98Carcinoma, Intraductal, Noninfiltrating 94Colonic Neoplasms 86Breast Cancer Lymphedema 86Pain 81Breast Cancer Female 76Anxiety Disorders 76Uterine Cervical Neoplasms 73Depression 70Triple Negative Breast Neoplasms 66Breast Carcinoma In Situ 66Head and Neck Neoplasms 55Pain, Postoperative 54Obesity 54Neoplasm Metastasis 48Melanoma 42Endometrial Neoplasms 39Pancreatic Neoplasms 38Lymphoma 38Carcinoma, Non-Small-Cell Lung 34Sleep Initiation and Maintenance Disorders 33Sarcoma 33

Interventions

disitamab vedotin 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Fulvestrant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase NA × Advanced Breast Cancer × Breast × Clear all
NCT05831878 2026-05-13

RC48-ADC in HER2-low Advanced Breast Cancer

RenJi Hospital

Phase NA Recruiting
36 enrolled
Breast

Advanced Breast Cancer

NCT05424068 2026-02-25

Rehabilitation for People With Advanced Cancer

University Health Network, Toronto

Phase NA Completed
111 enrolled
BreastGastrointestinal

Advanced Breast Cancer

NCT07428655 2026-02-24

Acceptability and Feasibility of PSC Model of Serious Illness Communication

National Cancer Centre, Singapore

Phase NA Active not recruiting
28 enrolled
Breast

Advanced Breast Cancer

NCT05876065 2025-09-11

Capecitabine and Cyclophosphamide (XC) as Maintenance Therapy for Advanced Breast Cancer

RenJi Hospital

Phase NA Recruiting
86 enrolled
Breast

Advanced Breast Cancer

NCT05047848 2021-09-17

Clinical Study of Chidamide Combined With Fulvestrant in the Treatment of Hormone Receptor-positive Advanced Breast Cancer

Liaoning Cancer Hospital & Institute

Phase NA Unknown
82 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡